Advertisement

How Should Marrow Transplantation be Approached?

  • H. J. Deeg

Abstract

Marrow transplantation is no longer a last desperate effort aimed only at salvaging patients with far advanced disease. Marrow transplantation in 1988 is a well established modality, which may acutally represent the treatment of choice for a given patient, and hence, should be part of treatment planning early in the patient’s course. This can be a demanding task, but the approach is generally rewarding both for physicians and patients. There must be no misunderstanding: marrow transplantation is a complex and expensive therapy. Results depend upon factors such as disease stage, patient age, histocompatibility, possibly donor age, and the patient’s overall medical condition. Some transplants, especially autologous, are still considered experimental and may not be covered by health insurance. Early recognition and discussion of potential problems may allow for them to be resolved, may direct therapeutic efforts in different directions, or may provide time needed to assure financing.

Keywords

Acute Lymphoblastic Leukemia Marrow Transplantation Aplastic Anemia Chronic Granulomatous Disease Transplant Center 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Appelbaum FR, Clift RA, Buckner CD, Stewart P, Storb R, Sullivan KM, Thomas ED (1983) Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. Blood 61: 949PubMedGoogle Scholar
  2. Beatty PG, Clift RA, Mickelson EM, Nisperos BB, Flournoy N, Martin PJ, Sanders JE, Stewart P, Buckner CD, Storb R, Thomas ED, Hansen JA (1985) Marrow transplantation from related donors other than HLA-identical siblings. New Eng J Med 313: 765PubMedCrossRefGoogle Scholar
  3. Butturini A, Rivera GK, Bortin MM, Gale RP (1987) Which treatment for childhood acute lymphoblastic leukaemia in second remission? The Lancet, I 429CrossRefGoogle Scholar
  4. Champlin R, Gale RP (1987) Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies. Seminars in Hematol 24: 55Google Scholar
  5. Doney K, Storb R, Bucker CD, McGuffin R, Witherspoon R, Deeg HJ, Appelbaum FR, Sullivan KM, Thomas EC (1987) Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. Exp Hematol 15: 239PubMedGoogle Scholar
  6. Friedrich W, Goldmann SF, Vetter U, Fliedner TM, Heymer B, Peter HH, Reisner Y, Kleihauer E (1984) Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow. The Lancet, I 761CrossRefGoogle Scholar
  7. Gluckman E, Berger R, Dutreix J (1984) Bone marrow transplantation for Fanconi anemia. Seminars in Hemat 21: 20Google Scholar
  8. Goldman JM, Apperley JF, Jones L, Marcus R, Goolden WG, Batchelor R, Hale G, Waldmann H, Reid CD, Hows J, Gordon-Smith E, Catovsky D, Galton DAG (1986) Bone marrow transplantation for patients with chronic myeloid leukemia. New Eng J Med 314: 202PubMedCrossRefGoogle Scholar
  9. Herzig RH, Bortin MM, Barrett AJ, Blume KG, Gluckman E, Horowitz MM, Jacobsen SJ, Marmont A, Masaoka T, Prentice HG, Ramsay NK, Rimm AA, Ringden O, Speck B, Zwaan FE, Gale RP (1987) Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission. The Lancet, I 786CrossRefGoogle Scholar
  10. Hoelzer D, Thiel E, Loffler H, Bodenstein H, Plaumann L, Buchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Muller U, Wendt FC, Sodomann H, Ruhl H, Herrmann F, Kaboth W, Dietzfelbinger H, Pralle H, Lunscken Ch, Hellriegel K-P, Spors S, Nowrousian RM, Fischer J, Fulle H, Mitrou PS, Pfreundschuh M, Gorg Ch, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, Konig H, Mainzer K, Herrmann R, Messerer D, Zwingers T (1984) Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64: 38PubMedGoogle Scholar
  11. Lucarelli G, Izzi T, Porcellini A, Delfini C, Galimberti M, Polchi P, Moretti L, Manna A, Sparaventi G (1983) Fetal liver transplant in aplastic anemia and acute leukemia. Recent Advances in Bone Marrow Transplantation R.P. Gale (ed.) Alan R. Liss, Inc. New York pp. 865Google Scholar
  12. O’Leary M, Ramsay NK, Nesbit ME, Hurd D, Woods WG, Krivit W, Kim TH, McGlave P, Kersey J (1983) Bone marrow transplantation for non-Hodgkin’s lymphoma in children and yound adults. Am J of Med 74: 497CrossRefGoogle Scholar
  13. Phillips GL, Herzig RH, Lazarus HM, Fay JW, Wolff SN, Mill WB, Lin HS, Thomas PR, Glasgow GP, Shina DC, Herzig GP (1984) Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. New Eng J Med 310: 1157CrossRefGoogle Scholar
  14. Preisler H, Davis RB, Kirshner J, Dupre E, Richards F, Hoagland HC, Kopel S, Levy RN, Carey R, Schulman P, Gottlieb AJ, Mclntyre OR, and the Cancer and Leukemia Group B (1987) Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study. Blood, 69: 1441PubMedGoogle Scholar
  15. Rivera GK, Buchanan G, Boyett JM, Camitta B, Ochs J, Kalwinsky D, Amylon M, Vietti TJ, Crist WM (1986) Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. New Eng J Med 315: 273PubMedCrossRefGoogle Scholar
  16. Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H, Mellits D, Sensenbrenner LL, Stuart RK, Yeager AM (1983) Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. New Eng J Med 309: 1347PubMedCrossRefGoogle Scholar
  17. Speck B, Gratwohl A, Nissen C, Osterwalder B, Wursch A, Tichelli A, Lori A, Reusser P, Jeannet M, Signer E (1986) Treatment of severe aplastic anemia. Exp Hematol 14: 126PubMedGoogle Scholar
  18. Storb R, Thomas ED, Buckner CD, Appelbaum FR, Clift RA, Deeg HJ, Doney K, Hansen JA, Prentice RL, Sanders JE, Stewart P, Sullivan KM, Witherspoon RP (1984) Marrow transplan tation for aplastic anemia. Seminars in Hemat 21: 27Google Scholar
  19. Thomas ED (1983) Marrow transplantation for malignant diseases. (Karnofsky Memorial Lecture) J Clin Oncol 1: 517PubMedGoogle Scholar
  20. Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, Buckner D, Cheever MA, Deeg HJ, Doney K, Flournoy N, Greenberg P, Hansen JA, Martin P, McGuffm R, Ramberg R, Sanders JE, Singer J, Stewart P, Storb R, Sullivan K, Weiden PL, Witherspoon R (1986) Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Int Med 104: 155PubMedGoogle Scholar
  21. Touraine JL (1983) European experience with fetal tissue transplantation in severe combined immunodeficiency. Birth Defects 19: 139PubMedGoogle Scholar
  22. Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelber RD (1983) Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 62: 315PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • H. J. Deeg

There are no affiliations available

Personalised recommendations